Are you a patient with advanced basal-like pancreatic adenocarcinoma? If so this could the a Trial for you to as this is a Phase I/II trial is to evaluate the safety, efficacy and tolerability of low-dose EGFR inhibitors in combination with bi-weekly gemcitabine/nab-paclitaxel (GnP) in subjects with basal tumors
The purpose of this study is to test a brain stimulation device in Adults with Depression. We aim to make sure the device functions as designed and appropriately stores and transmits data.
The purpose of this research study is to gain insight into how people interact with some of Spotify's features including Discover Weeklyl, DJ, and Daylist. We want to learn more about the factors that influence how users discover new music when using these features.
The purpose of this research study is to investigate how human interpret some predictive learned by AI systems when detecting deceptive hotel reviews and how AI explanations can shape human understanding. For instance, the AI system learns that words like "floor" and "bathroom" are highly predictive of genuine reviews and words like "husband" and "luxury" are highly predictive of deceptive reviews. While the AI system highlights these words by learning from the data, the association between these words and the outcome are not easy to comprehend for humans. Thus, our goal of this research is to investigate how participants interact with machine-generated explanations that are unintuitive, and how participants make use of our developed visualizations and tools to make sense of these unintuitive features.
The purpose of this study is to test the safety and effectiveness of the test drug IMGN151-1001 on your cancer.
In this study, we want to see how people's bodies react to alcohol in the lab and outside of it. We want to examine responses to alcohol and drinking behavior in people who drink alcohol regularly.
In this study, we want to see how giving birth affects stress chemicals in the body. We will focus on a stress hormone called cortisol and check its levels in people who gave birth, from 3 to 12 months after giving birth.
Are you 14 to 20 weeks pregnant with one baby? If so, you may be able to take part in a study on how stress and discrimination during pregnancy affect your health. We want to prevent high blood pressure and give better care to pregnant women.
Have you been diagnosed with relapsed or refractory light chain amyloidosis? If so, you may be able to take part in a research study looking at the safety and tolerability of giving Venetoclax, MLN9708 (ixazomib citrate) and Dexamethasone to patients with relapsed or refractory light chain amyloidosis.
Have you been diagnosed with aggressive B-cell lymphomas and received CAR-T treatment? If so, you may be able to take part in a research study. This study is looking at the efficacy of giving an investigational drug called Epcoritamab in comparison with no treatment. The participants should have received CAR-T treatment but did not have complete remission.